KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ)

$8.8 -1.02 (-10.387%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 73

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) News Sources

Karyopharm Therapeutics Inc (KPTI) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...

14-05-2026

yahoo.com

Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting

25-05-2026

yahoo.com

Karyopharm Therapeutics Teases ASCO SENTRY Data as FDA Path Comes Into Focus

26-05-2026

marketbeat.com

Karyopharm Therapeutics Spotlights Selinexor Milestones, ASCO Data and Cancer Trial Readouts

26-05-2026

marketbeat.com

Wall Street Analysts Think Karyopharm Therapeutics (KPTI) Could Surge 70.46%: Read This Before Placing a Bet

27-05-2026

yahoo.com

Karyopharm to Participate at the 2026 Jefferies Global Healthcare Conference

28-05-2026

yahoo.com

Karyopharm to Host Investor Conference Call Featuring Expert Perspectives on the Phase 3 SENTRY Trial in Myelofibrosis Following 2026 ASCO Presentation

01-06-2026

yahoo.com

Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

01-06-2026

yahoo.com

Karyopharm to Present Results from Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis in Late-Breaking Oral Presentation at ASCO 2026 with Simultaneous Publication in the Journal of Clinical Oncology

02-06-2026

yahoo.com

Karyopharm's Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis Selected for Late-Breaking Oral Presentation at EHA 2026

02-06-2026

yahoo.com

KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) Sentiment Trend

0 25 50 75 100 90 72 88 85 7 88 87 65 69 76 14-05-2026 25-05-2026 26-05-2026 27-05-2026 28-05-2026 01-06-2026 02-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) FAQs

toggle

What is the current price of KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ)?

The current price of KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) is $8.8.


toggle

KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) absolute price change since previous trading day?

The absolute price change of KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) since the previous trading day is $-1.02.


toggle

KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) percentage price change since previous trading day?

The percentage price change of KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) since the previous trading day is -10.387%.


toggle

What is the most recent average sentiment score for KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ)?

The most recent average sentiment score for KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) is 73 out of 100.


toggle

What is the most recent average sentiment for KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ)?

The most recent sentiment for KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) is .


SEC-8K** Filing Available For KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.